Moderna's vaccine triggers immune response
The first coronavirus vaccine tested in humans in the U.S. triggered an immune response and is moving to Phase 3 trials. Dr. David Agus explains what this means for the fight against the virus.
Vaccine
Pfizer to provide U.S. with 100 million COVID-19 vaccine doses
U.S. government will pay pharmaceutical firms almost $2 billion, with a pledge to provide the vaccines for free.
U.S. charges Chinese hackers with targeting vaccine research
The Department of Justice on Tuesday indicted two Chinese nationals who are accused of targeting COVID-19 research. Officials say the defendants never obtained any research, but face 11 charges including trade secret theft and wire fraud conspiracy. CBS News senior investigative correspondent Catherine Herridge joins CBSN's Errol Barnett with the latest.
Feds charge Chinese cyber hackers who targeted COVID-19 research
The two hackers also allegedly stole millions of dollars' worth of trade secrets and private business information.
School reopenings may trigger outbreaks
Coronavirus cases are on the rise in dozens of states even as schools prepare to reopen for the fall. CBS News' Laura Podesta reports on the latest developments, and pediatrician Dr. Dyan Hes joins CBSN to discuss a new study out of South Korea that suggests school reopenings will trigger more outbreaks, plus the likelihood of pregnant women passing the virus to their babies.
Moderna CEO hiked his stock sales after vaccine news announced
Changes to executive stock-sale plans in May allowed hot biotech's top two leaders to cash out an extra $4 million in July.
Oxford COVID vaccine trial results called "extremely encouraging"
AstraZeneca says the trial data "increases our confidence that the vaccine will work and allows us to continue our plans to manufacture the vaccine at scale."
Hackers with "direct link" to Russian state targeting vaccine work
"These aren't common criminals," former U.K. spy agency chief says of "Cosy Bear" hackers accused of going after COVID-19 research.
Russian hackers accused of targeting vaccine
A Russian-backed hacking group is believed to have targeted organizations working on a coronavirus vaccine. CBS News foreign correspondent Charlie D'Agata reports from London, where the world's leading clinical trials might be at risk, and CBS News senior investigative correspondent Catherine Herridge joined CBSN to discuss.
U.S. again shatters new COVID case record
As labs struggle to keep up with growing testing demands and battles intensify over face-covering mandates and school-reopening plans, the U.S. has once again shattered its record of new coronavirus infections. CBS News' Naomi Ruchim reports on the latest developments, and Dr. Bob Lahita joined CBSN to discuss a new push to reduce what one U.S. official called "unnecessary" testing for COVID-19.
Russia-backed hackers target COVID-19 vaccine
British and American intelligence officials said prominent hacking group APT29, responsible for hacking DNC servers in 2016, has targeted coronavirus vaccine-related work. CBS foreign correspondent Charlie D'Agata reports on the intelligence community's response and the rising security risks during the pandemic.
U.S., U.K. and Canada say Russian hackers are targeting COVID vaccine research
The three countries warned that the group known as APT29 — also referred to as "the Dukes" or "Cozy Bear" — was behind the attacks.
First coronavirus vaccine tested in U.S. moves forward
Nearly two dozen possible COVID-19 vaccines are in various stages of testing around the world. Candidates from China and Britain's Oxford University also are entering final testing stages.
COVID-19 data being shifted away from CDC
Coronavirus cases, hospitalizations, and deaths continue to rise across parts of the U.S. CBS News' Laura Podesta reports on the latest, and Dr. Neeta Ogden joins CBSN to discuss concerns about a new order from the White House that shifts control of data on COVID-19 to the Department of Health and Human Services instead of the CDC.
Facebook boycott leaders slam Zuckerberg
Civil rights leaders say that Facebook isn't doing enough to stop the spread of hate speech on its platform. Imran Ahmed, the founder and CEO of the Center for Countering Digital Hate, joins CBSN to discuss how big tech companies are profiting from misinformation.
"Explosively large" surge in COVID cases
Novavax is the latest company to get $1.6 billion in federal funding to develop and distribute a coronavirus vaccine by early 2021. This comes as cases surge in states like Texas and Florida. Internal medicine specialist, Dr. Neeta Ogden joins CBSN to discuss the latest details
U.S. commits $1.6 billion to Novavax coronavirus vaccine
The funding for the coronavirus vaccine candidate being developed by Novavax comes as part of Operation Warp Speed.
Non-government experts could pick who gets COVID-19 vaccine first
The National Institutes of Health director said "people are a little uneasy about the government calling the shots here"
Pfizer shows promise in vaccine trial
Pfizer and BioNTech reported encouraging signs in early clinical trials of a possible COVID-19 vaccine. The small study triggered stronger immune responses in recipients. More than 15 different possible vaccines are being tested on people worldwide. Dr. David Agus joined "CBS This Morning" with the latest on the global vaccine effort.
Study: Protests did not lead to COVID spike
New research suggests the massive Black Lives Matter protests across the country have not led to a jump in coronavirus cases. Dr. Ron Elfenbein joined CBSN to discuss why researchers believe the there's been no surge tied to large groups of demonstrators, even while cases spike in a number of states that reopened early.
Fauci warns U.S. "unlikely" to reach herd immunity if many Americans refuse vaccine
Fauci said in an interview for the Aspen Ideas Festival he would "settle" for a coronavirus vaccine that is between 70% and 75% effective.
Rules stop gay men from donating antibodies
Scientists are racing to find a vaccine or treatment for COVID-19, and the FDA has loosened restrictions on blood donations from homosexual men as antibody tests may be crucial in find a cure. But some restrictions still remain. GLAAD's Chief Communications Officer Rich Ferarro joins CBSN to discuss the issue.
Experts say Indian capital's plan to stop COVID is "a waste of time"
Delhi is preparing thousands of makeshift hospital beds ahead of an expected surge in COVID-19 cases, which disease experts say could have been avoided.
Nursing homes face COVID risks
More than 54,000 people living and working in long-term care facilities have died from the coronavirus pandemic in the U.S. Many facilities are now starting to reopen to visitors. Dr. Dillard Elmore, senior vice president and director of Daikon Medical Group and corporate medical director for Daikon Senior Living Services, joined CBSN to discuss how nursing homes are grappling with keeping residents safe and maintaining their quality of life.
Promising vaccine trial pushes into COVID-swamped South Africa, Brazil
Oxford University team's drug is a leading contender, but there isn't enough virus still circulating in England for a trial there to work alone.
3 children, 1 teacher killed in Oregon school shooting, police say
Vance says "selling access to the White House" is "disgusting"
Exclusive
Alleged Chinese agent has ties to scam group, records show
Live
Iran says Strait of Hormuz will reopen if U.S. leaves region
"Flying cars are real": Musk debuts the new Tesla Roadster
American journalist injured in West Bank clashes
White House prepares plans to use "mother of all bombs" on Iran
Exclusive
Ousted general warned of missile defense shortage before Iran war
